Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Johnson & Johnson Loses $63 Million Verdict In Motrin Case-Reuters


Wednesday, 13 Feb 2013 06:54pm EST 

Reuters reported that A Massachusetts jury said Johnson & Johnson must pay a teenage girl and her family $63 million, finding she lost much of her skin and suffered other serious harm after taking the Company's Motrin painkiller in 2003. The Plymouth Superior Court jury found that Samantha Reckis developed Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis after taking Children's Motrin when she was 7 years old. 

Company Quote

106.7
-0.18 -0.17%
25 Nov 2014